At a glance
ClinicalIndex Comparison RecordN/ACompleted· 37 enrolled
Drug / intervention
Intrauterine ultrasound guided radio-frequency ablationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids
In Brief
An observational study evaluating Intrauterine ultrasound guided radio-frequency ablation for Uterine Fibroids and Adhesions. Completed, enrolled 37 participants across 6 sites in 4 countries.
Detailed Summary
This study is designed to observe the presence or absence of intrauterine adhesions at 6 weeks after treatment with the Sonata® System through hysteroscopic evaluation by third party readers.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsUterine Fibroids, Adhesions
CountriesGermany, Netherlands, Switzerland, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 2016
Enrollment StartJul 2017
Primary CompletionAug 2018
TodayJul 2026
First PostedJul 26, 2016
Enrollment StartJul 20, 2017
Primary CompletionAug 27, 2018
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.9 years ago
Interventions
Intrauterine ultrasound guided radio-frequency ablationdevice
Radiofrequency ablation for the treatment of uterine fibroids